Willie Wyatt
Family Medicine · Oklahoma City, OKNPI 1538199443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $926 and has fallen 97.4% since, to $24 in 2025.
Across 189 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$565
- Amarin Pharma, Inc.$476
- AstraZeneca$276
- Lilly USA, LLC$242
- AbbVie$227
- Bayer$204
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,371100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 32 | $565 |
| Amarin Pharma, Inc. | 16 | $476 |
| AstraZeneca | 20 | $276 |
| Lilly USA, LLC | 16 | $242 |
| AbbVie(2 entities) | 13 | $227 |
| Bayer | 12 | $204 |
| Astellas Pharma US Inc | 9 | $163 |
| Novo Nordisk | 9 | $161 |
| Boehringer Ingelheim | 9 | $155 |
| Abbott | 6 | $124 |
| GSK | 6 | $107 |
| Pfizer | 5 | $87 |
| Sanofi-aventis U.S. LLC | 5 | $78 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $68 |
| Ultragenyx Pharmaceutical Inc. | 3 | $57 |
| Merck | 3 | $44 |
| Novartis | 3 | $39 |
| Sunovion Pharmaceuticals Inc. | 2 | $37 |
| Exact Sciences | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Antares Pharma, Inc. | 2 | $31 |
| Ironwood Pharmaceuticals, Inc | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Adlon Therapeutics L.p. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Halozyme Inc | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,371 in reported general payments places this provider in the 80th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Oklahoma City
- Alexander FrankOklahoma City$3.1M
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- John PittmanOklahoma City$39K
- Terrence TruongOklahoma City$32K
- Jonathon KnoxOklahoma City$20K
- Steven SacketOklahoma City$17K
- Stanley CorleyOklahoma City$16K
- Teddy WebbOklahoma City$15K
- Judy MagnussonOklahoma City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.